Business. Scoop » Growing Demand For Precision ECG Tools Reshapes Cardiovascular Research Equipment Market
Press Release – ADInstrumentsBeyond hardware and electrode placement, the quality of analytical tools plays a central role in the value researchers extract from ECG recordings. The global market for ECG. . .
Press Release – ADInstrumentsBeyond hardware and electrode placement, the quality of analytical tools plays a central role in the value researchers extract from ECG recordings. The global market for ECG equipment and management systems is experiencing sustained growth, driven by rising investment in cardiovascular research and an increasing need for accurate physiological data acquisition. According to Precedence Research, the market was valued at US$7. 75 billion (approximately NZ$13. 18 billion) in 2024 and is projected to reach US$13. 97 billion (approximately NZ$23. 75 billion) by 2034, reflecting a compound annual growth rate of 6. 07%. This expansion is pushing research institutions to prioritise both hardware reliability and software sophistication when selecting ECG systems. For researchers conducting human subject studies, methodological rigour begins with correct electrode positioning. Errors in lead placement can compromise signal quality and skew downstream analysis, making standardised guidance increasingly important. Laboratories seeking reliable protocols can refer to resources such as a detailedECG placement guideto ensure consistent, reproducible recordings across study participants and research teams. Beyond hardware and electrode placement, the quality of analytical tools plays a central role in the value researchers extract from ECG recordings. Demand for integratedECG DAQ softwarehas grown as investigators seek automated detection of PQRST waveform components, real-time interval reporting, and seamless compatibility with existing data acquisition platforms. Dunedin-based ADInstruments has positioned its ECG Analysis Module for LabChart to address precisely these needs, offering automated waveform analysis within the broader PowerLab and LabChart ecosystem used by physiology and cardiovascular research labs worldwide. The broader life science instrumentation sector reinforces this trajectory. MarketsandMarkets values the global life science instrumentation market at US$59. 9 billion (approximately NZ$101. 8 billion) in 2024, with growth to US$92. 5 billion (approximately NZ$157. 3 billion) expected by 2031. As research budgets tighten and expectations for data quality rise, institutions are increasingly drawn to unified platforms that reduce fragmentation and support collaborative workflows across multi-researcher and multi-campus environments. Content Sourced fromscoop. co. nzOriginal url